glaxosmithklineInsuranceNational Newspatent infringementpatent litigationpharmaceutical industryTeva
Supreme Court Rejects Teva Challenge to $235 Million GSK Award in Patent Dispute
New You can now listen to Insurance Journal articles! The U.S. Supreme Court on Monday declined to hear Teva Pharmaceuticals…